dalteparin has been researched along with oligonucleotides in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bethune, C; Bhanot, S; Büller, HR; Gailani, D; Monia, BP; Raskob, GE; Segers, A; Verhamme, P; Weitz, JI | 1 |
1 trial(s) available for dalteparin and oligonucleotides
Article | Year |
---|---|
Factor XI antisense oligonucleotide for prevention of venous thrombosis.
Topics: Adult; Aged; Anticoagulants; Arthroplasty, Replacement, Knee; Blood Coagulation; Clinical Protocols; Enoxaparin; Factor XI; Female; Hemorrhage; Humans; Length of Stay; Male; Middle Aged; Oligonucleotides; Oligonucleotides, Antisense; Partial Thromboplastin Time; Postoperative Complications; Venous Thrombosis | 2015 |